- Will This FIFA Stadium Collapse Delay Advanced Biofuels?
A stadium collapse in the city of Sao Paulo will put added pressure on Brazil's already stressed construction sector and could lead to an increase in construction costs. What does it mean for companies such as Cosan, Amyris, and Solazyme, which are all planning construction projects in the country?
- 30 Captivating Facts Celebrating an Important Biotech Breakthrough
The invention of polymerase chain reaction, or PCR, in 1983 may not be directly relevant to everyday investors, but it has gone a long way in spurring innovation in biopharmaceuticals, biotech crops, and industrial biotech. If you own a company in one of those industries, then it's likely that you should pay your respects to PCR.
- How 23andMe Can Spur Growth for These Diagnostics Companies
Direct-to-consumer genetic tests took a hit when the Food and Drug Administration told 23andMe to stop marketing its product. However, accepting the arrival of accessible genetic information could ignite growth opportunities for Myriad Genetics, Genomic Health, and Quest Diagnostics.
- Can GMO Labeling Laws in Connecticut and Maine Survive?
The country watched as voters in Washington weighed in on whether or not to enact GMO labeling laws affecting several food products in the state. However, Connecticut and Maine passed similar legislation back in June. Can a built-in compromise succeed in establishing the nation's first GMO labeling law?
- Is the FDA Denying You Access to Your Genome?
The Food and Drug Administration recently removed a personal genome kit offered by 23andMe from the market. Here's why it was the right move.
- Is Isobutanol the Perfect Olive Branch for the EPA?
The agency must acknowledge concerns regarding the Blend Wall with gasoline, but a viable alternative to ethanol isn't readily available. Can isobutanol offer the perfect solution, and a massive opportunity for BP and DuPont?
- Why Voters in Washington Are Right About GMO Labeling
Voters in Washington state struck down the proposal that would have made GMO labeling law. Here's why they got it right.
- Regulatory Similarities Between GMO Foods and Pharmaceuticals
Numerous polls show that the majority of consumers fear that GMO foods and ingredients pose a risk to their health. Unfortunately, people tend to dismiss the scientific data that shows otherwise. Can a review of the regulatory process for GMO foods quell public fears?
- This Biodiesel Stock Is on Sale
The Environmental Protection Agency may have proposed to reduce the overall amount of biodiesel blendstocks required to be blended into the nation's fuel supply for next year, but I don't think that justifies a drop of more than 20% for shares of Renewable Energy Group.
- Organovo + Lab-Grown Meat = Return of the Dollar Menu?
Wait -- tissue engineering can help save the planet AND bring back the Dollar Menu?